RET and medullary thyroid gland carcinoma: MTC progression has been described as age-related in several RET mutations and a large retrospective study described a ‘window of opportunity’ marked off as the youngest age of node-positive MTC described in each mutational risk category (for moderate risk- 15 years and for high risk- 9 years (16)).